EP3013335
COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING ERIBULIN AND LENVATINIB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.6.2014EP published:
7.11.2018EP application number:
14739971.1
EPO information:
European Patent Register
Max expiry date:
25.6.2034
Title:
COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING ERIBULIN AND LENVATINIB
Timeline
Today
26.6.2014EP application
7.11.2018EP Publication
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome Bunkyo-ku, 112-8088, Tokyo, JP
Inventor
Name:
NOMOTO, KenichiAddress:
Belmont, Massachusetts, US
Name:
WU, JiayiAddress:
Brookline, Massachusetts, US
Priority
Number:
201361839542 PDate:
26.6.2013Country:
US
Classification
Categories:
A61K 31/357, A61K 31/47, A61K 45/06, A61P 35/00, A61P 35/02, A61P 35/04